JUPITER, Fla.--(BUSINESS WIRE)--Dyadic International, Inc. (AMEX:DIL), a biotechnology company, announced today that it has closed the previously announced three-year research and development (R&D) agreement and stock purchase agreement with Abengoa Bioenergy R&D, Inc. (Abengoa), an Abengoa Bioenergy Company. Under the terms of the stock purchase agreement, Abengoa Bioenergy has purchased 2,136,752 shares of Dyadic Common Stock at $4.68 per share, or a total of $10 million.
